# Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

> **NCT02320045** · PHASE1 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 38 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** ITCA 650 (Exenatide in osmotic mini pump)

## Key facts

- **NCT ID:** NCT02320045
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02320045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02320045, "Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02320045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*